About Rudolph Tanzi
Form D filings for Acta Pharmaceuticals from 2023 to 2024 list Rudolph Tanzi as director.
Rudolph Tanzi first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Rudolph Tanzi in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Rudolph Tanzi works with at each company, as listed on that company's latest Form D.
Acta Pharmaceuticals, Inc. · Form D/A, Apr 22, 2024
GA
George Alex
President and director
TP
Thierry Porte
Director